5-alpha reductase inhibitors interfere
with the effect of certain male hormones (androgens) on the prostate. This
slows the growth of the prostate and can even cause it to become smaller, which
may help improve the symptoms of
benign prostatic hyperplasia (BPH).
since prostate size does not always correspond to the severity of a man's
symptoms, these medicines will not give satisfactory results in every case.
When you stop taking the medicine, symptoms usually
5-alpha reductase inhibitors are used to keep symptoms of BPH from getting worse. They are also used to reduce the risk of being unable to urinate (urinary retention) and to prevent surgery for BPH.
5-alpha reductase inhibitors are also used to treat the symptom of blood in the urine because of BPH.
5-alpha reductase inhibitors are not
recommended for men who have BPH symptoms without a noticeably enlarged prostate.
5-alpha reductase inhibitors may be prescribed for men who have bothersome,
moderate symptoms of BPH.
Most men who use 5-alpha reductase
inhibitors report about a 3-point decrease in their
American Urologic Association (AUA) symptom index.
This change represents a noticeable improvement in symptoms.1
5-alpha reductase inhibitors also decrease the risk of
complications, such as being unable to urinate (urinary retention). And they make it
less likely that you will need surgery.2
It may take 6 to 12 months before you notice that your symptoms have improved.
Using a combination of an alpha-blocker with a
5-alpha reductase inhibitor long-term may help your symptoms more than either medicine
Side effects may include:
These side effects may go away after a year or more of taking the medicine.
It is possible that 5-alpha reductase inhibitors are linked to an increased risk for high-grade prostate cancers. But more research is needed.
See Drug Reference for a full list of side effects. (Drug Reference is
not available in all systems.)
5-alpha reductase inhibitors
reduce the size of the prostate. But since a smaller size does not always
relieve symptoms, these medicines will not give satisfactory results
in every case. When you stop taking the medicine, symptoms usually
5-alpha reductase inhibitors lower prostate-specific
antigen (PSA) levels. Because PSA levels are used to detect early-stage
prostate cancer, men interested in taking a 5-alpha reductase inhibitor might
consider the following:
5-alpha reductase inhibitors are not recommended for treatment of BPH symptoms
in men who do not have an enlarged prostate.1
The medicine must be taken for the rest of your life to prevent the
symptoms from coming back.
This medicine should not be used by men
who plan to father a child, because there is a small chance that the medicine could
cause a birth defect. Women who are pregnant or might become pregnant should
not handle broken or crushed tablets of finasteride or dutasteride.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
AUA Practice Guidelines Committee (2010). AUA guideline on management of benign prostatic hyperplasia. Chapter 1: Guideline on the management of benign prostatic hyperplasia (BPH). Available online: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph.
McNicholas T, Kirby R (2011). Benign prostatic hyperplasia, search date July 2009. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
Roehrborn CG, et al. (2008). The effects of
dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms
in men with benign prostatic hyperplasia and prostatic enlargement: 2-year
results from the CombAT study. Journal of Urology,
March 5, 2012
E. Gregory Thompson, MD - Internal Medicine
& J. Curtis Nickel, MD, FRCSC - Urology
How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.